Terms: = Gastric cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Prognosis
14 results:
1. The Naples Prognostic Score Is an Independent Prognostic Factor for gastric cancer Patients Who Receive Curative Treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Tamagawa H; Tamagawa A; Nagasawa S; Cho H; Segami K; Nakazono M; Otani K; Sawazaki S; Numata M; Kamiya N; Yoshizawa S; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(2):890-896. PubMed ID: 38418121
[TBL] [Abstract] [Full Text] [Related]
2. Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial.
Zhang L; Wang W; Ge S; Li H; Bai M; Duan J; Yang Y; Ning T; Liu R; Wang X; Ji Z; Wang F; Zhang H; Ba Y; Deng T
BMC Cancer; 2023 Mar; 23(1):211. PubMed ID: 36872337
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
[TBL] [Abstract] [Full Text] [Related]
4. Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients.
Lu H; Sun Y; Zhu Z; Xu H; Huang R; Huang B
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1329-1336. PubMed ID: 34431734
[TBL] [Abstract] [Full Text] [Related]
5. Value of HMGB1 expression for assessing gastric cancer severity: a systematic meta-analysis.
Zhou C; Yang Q
J Int Med Res; 2021 Mar; 49(3):300060521993312. PubMed ID: 33682495
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma.
Saad ZM; Fouad Y; Ali LH; Hassanin TM
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
[TBL] [Abstract] [Full Text] [Related]
7. Nutritional Indexes as Predictors of Survival and Their Genomic Implications in gastric cancer Patients.
Sánchez Y; Vaca-Paniagua F; Herrera L; Oñate L; Herrera-Goepfert R; Navarro-Martínez G; Cerrato D; Díaz-Velázquez C; Quezada EM; García-Cuellar C; Prada D
Nutr Cancer; 2021; 73(8):1429-1439. PubMed ID: 32715775
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of Inflammation-Based Prognostic Scores Associated with the Prognostic Impact of Adenocarcinoma of Esophagogastric Junction and Upper gastric cancer.
Kudou K; Nakashima Y; Haruta Y; Nambara S; Tsuda Y; Kusumoto E; Ando K; Kimura Y; Hashimoto K; Yoshinaga K; Saeki H; Oki E; Sakaguchi Y; Kusumoto T; Ikejiri K; Shimokawa M; Mori M
Ann Surg Oncol; 2021 Apr; 28(4):2059-2067. PubMed ID: 32661855
[TBL] [Abstract] [Full Text] [Related]
9. Causes of death in patients diagnosed with gastric adenocarcinoma in Sweden, 1970-2014: A population-based study.
Xie SH; Chen H; Lagergren J
Cancer Sci; 2020 Jul; 111(7):2451-2459. PubMed ID: 32359209
[TBL] [Abstract] [Full Text] [Related]
10. Association between density of tumor-infiltrating lymphocytes and prognoses of patients with gastric cancer.
Yu PC; Long D; Liao CC; Zhang S
Medicine (Baltimore); 2018 Jul; 97(27):e11387. PubMed ID: 29979429
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses.
Xia P; Xu XY
Oncotarget; 2016 Jul; 7(29):45538-45546. PubMed ID: 27323782
[TBL] [Abstract] [Full Text] [Related]
12. Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.
Aparicio T; Svrcek M; Zaanan A; Beohou E; Laforest A; Afchain P; Mitry E; Taieb J; Di Fiore F; Gornet JM; Thirot-Bidault A; Sobhani I; Malka D; Lecomte T; Locher C; Bonnetain F; Laurent-Puig P
Br J Cancer; 2013 Dec; 109(12):3057-66. PubMed ID: 24196786
[TBL] [Abstract] [Full Text] [Related]
13. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.
He W; Tang B; Yang D; Li Y; Song W; Cheang T; Chen X; Li Y; Chen L; Zhan W; Li W; He Y
World J Surg Oncol; 2013 Jul; 11():161. PubMed ID: 23866030
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic factors for patients after curative resection for proximal gastric cancer.
Zhao D; Xu H; Li K; Sun Z
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):530-5. PubMed ID: 20714884
[TBL] [Abstract] [Full Text] [Related]
